Table 32.
Country | Gentamicin | Co‐amoxiclav | Ciprofloxacin | Erythromycin | Tetracyclines | |||||
---|---|---|---|---|---|---|---|---|---|---|
N | % Res | N | % Res | N | % Res | N | % Res | N | % Res | |
Austria | 376 | 0.3 | – | – | 376 | 71.5 | 376 | 0 | 376 | 41.5 |
Cyprus | – | – | – | – | 38 | 86.8 | 38 | 0 | 38 | 86.8 |
Denmark | 294 | 0.7 | – | – | 294 | 33.3 | 294 | 1.0 | 294 | 16.0 |
Estonia | – | – | – | – | 194 | 91.2 | 196 | 0 | 196 | 63.8 |
Finlanda | – | – | – | – | 2,923 | 61.0 | 2,776 | 2.8 | 1,097 | 44.2 |
Franceb | 5,108 | 0.3 | 5,614 | 0.2 | 5,616 | 55.3 | 5,615 | 0.6 | 5,390 | 46.8 |
Italy | 74 | 4.1 | – | – | 80 | 85.0 | 80 | 3.8 | 80 | 67.5 |
Lithuaniab | – | – | – | – | 289 | 86.9 | 329 | 6.1 | 275 | 63.6 |
Luxembourg | – | – | 457 | 4.8 | 457 | 63.2 | 457 | 0.2 | 457 | 46.2 |
Malta | 7 | NA | 8 | NA | 134 | 55.2 | 133 | 5.3 | 8 | NA |
Netherlandsb | – | – | – | – | 2,401 | 56.1 | 2,102 | 1.9 | 1,715 | 39.0 |
Portugal | 167 | 0.6 | – | – | 167 | 94.0 | 167 | 6.6 | 167 | 82.0 |
Romania | 18 | 0 | 18 | 0 | 18 | 77.8 | 18 | 0 | 18 | 44.4 |
Slovakiab | 34 | 2.9 | 109 | 2.8 | 639 | 51.8 | 862 | 1.0 | 665 | 27.2 |
Slovenia | – | – | – | – | 1,192 | 66.4 | 1,193 | 0.4 | 1,192 | 37.2 |
Spain | 265 | 1.1 | – | – | 265 | 84.5 | 265 | 2.6 | 265 | 78.5 |
United Kingdomb | 32 | 0 | – | – | 7,593 | 44.4 | 7,092 | 3.3 | 3,381 | 36.3 |
Total (17 MSs) | 6,375 | 0.4 | 6,206 | 0.6 | 22,676 | 54.6 | 21,993 | 2.1 | 15,614 | 42.8 |
Icelandb | – | – | – | – | 60 | 13.3 | 60 | 0.0 | – | – |
Norway | 173 | 0.6 | – | – | 171 | 41.5 | 173 | 11.6 | 173 | 19.7 |
N: number of isolates tested; % Res: percentage of resistant isolates (either non‐wild type by ECOFFs or clinically non‐susceptible by combining resistant and intermediate categories); –: no data reported; NA: not applicable – if fewer than 10 isolates were tested, resistance was not calculated.
Travel‐associated cases, accounting for 75% of Campylobacter infections in Finland in 2015, could not be excluded from the Finnish AST data.
Data interpreted with clinical breakpoints.